Dr. Stanley M. Marks
Overview
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania.
Dr. Marks is rated as an Experienced provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.
His clinical research consists of co-authoring 9 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 5th Avenue, Mckeesport, PA 15132
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as a Distinguished provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.
UPMC Hillman Cancer Center
Rahim A. Remtulla, MD, FACP, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Remtulla specializes in the evaluation and treatment of all generalized oncology cases, various hematologic malignancies ; including chronic leukemia, multiple myeloma, lymphomas ; and benign hematologic conditions. Dr. Remtulla is rated as an Advanced provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Pulmonary Embolism, Thrombocytopenia, Pleuropulmonary Blastoma, and Lung Cancer.
Michael Voloshin is a Hematologist Oncology specialist and a Hematologist in Johnstown, Pennsylvania. Dr. Voloshin is rated as a Distinguished provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Anemia, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Gastric LymphomaDr. Marks isDistinguished. Learn about Gastric Lymphoma.
- Non-Hodgkin LymphomaDr. Marks isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Primary Lymphoma of the BrainDr. Marks isDistinguished. Learn about Primary Lymphoma of the Brain.
- Advanced
- B-Cell LymphomaDr. Marks isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Marks isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Marks isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Classical Hodgkin LymphomaDr. Marks isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Follicular LymphomaDr. Marks isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Lymphoblastic Leukemia (ALL)Dr. Marks isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adenoid Cystic CarcinomaDr. Marks isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Marks isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Marks isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer